Industrial Psychiatry Journal

CASE REPORT
Year
: 2010  |  Volume : 19  |  Issue : 1  |  Page : 58--59

Use of propofol as adjuvant therapy in refractory delirium tremens


Rajiv Mahajan1, Rakendra Singh2, Pir Dutt Bansal3, Ranju Bala4 
1 Department of Pharmacology, Adesh Institute of Medical Sciences and Research, Bathinda, India
2 Department of Medicine, Adesh Institute of Medical Sciences and Research, Bathinda, India
3 Department of Psychiatry, Adesh Institute of Medical Sciences and Research, Bathinda, India
4 Department of Anaesthesia and Critical Care, Adesh Institute of Medical Sciences and Research, Bathinda, India

Correspondence Address:
Rajiv Mahajan
Department of Pharmacology, Adesh Institute of Medical Sciences and Research, Bathinda - 151 109
India

Delirium tremens is recognized as a potentially fatal and debilitating complication of alcohol withdrawal. Use of sedatives, particularly benzodiazepines, is the cornerstone of therapy for delirium tremens. But sometimes, very heavy doses of benzodiazepines are required to control delirious symptoms. We are reporting one such case of delirium tremens, which required very heavy doses of benzodiazepines and was ultimately controlled by using infusion of propofol. Thus propofol should always be considered as an option to treat patients with resistant delirium tremens.


How to cite this article:
Mahajan R, Singh R, Bansal PD, Bala R. Use of propofol as adjuvant therapy in refractory delirium tremens.Ind Psychiatry J 2010;19:58-59


How to cite this URL:
Mahajan R, Singh R, Bansal PD, Bala R. Use of propofol as adjuvant therapy in refractory delirium tremens. Ind Psychiatry J [serial online] 2010 [cited 2022 Nov 26 ];19:58-59
Available from: https://www.industrialpsychiatry.org/article.asp?issn=0972-6748;year=2010;volume=19;issue=1;spage=58;epage=59;aulast=Mahajan;type=0